BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38308299)

  • 1. Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells.
    Victorio CBL; Novera W; Ganasarajah A; Ong J; Thomas M; Wu J; Toh HSY; Sun AX; Ooi EE; Chacko AM
    J Transl Med; 2024 Feb; 22(1):126. PubMed ID: 38308299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.
    Chen Q; Wu J; Ye Q; Ma F; Zhu Q; Wu Y; Shan C; Xie X; Li D; Zhan X; Li C; Li XF; Qin X; Zhao T; Wu H; Shi PY; Man J; Qin CF
    mBio; 2018 Sep; 9(5):. PubMed ID: 30228241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic Zika Virus: New Option for Glioblastoma Treatment.
    Zhou C; Chen Q; Chen Y; Qin CF
    DNA Cell Biol; 2023 Jun; 42(6):267-273. PubMed ID: 36350682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy.
    Calderón-Peláez MA; Maradei Anaya SJ; Bedoya-Rodríguez IJ; González-Ipuz KG; Vera-Palacios D; Buitrago IV; Castellanos JE; Velandia-Romero ML
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.
    Nair S; Mazzoccoli L; Jash A; Govero J; Bais SS; Hu T; Fontes-Garfias CR; Shan C; Okada H; Shresta S; Rich JN; Shi PY; Diamond MS; Chheda MG
    JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33232299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Susceptibility of Ex Vivo Primary Glioblastoma Tumors to Oncolytic Effect of Modified Zika Virus.
    Garcia G; Chakravarty N; Paiola S; Urena E; Gyani P; Tse C; French SW; Danielpour M; Breunig JJ; Nathanson DA; Arumugaswami V
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin α
    Zhu Z; Mesci P; Bernatchez JA; Gimple RC; Wang X; Schafer ST; Wettersten HI; Beck S; Clark AE; Wu Q; Prager BC; Kim LJY; Dhanwani R; Sharma S; Garancher A; Weis SM; Mack SC; Negraes PD; Trujillo CA; Penalva LO; Feng J; Lan Z; Zhang R; Wessel AW; Dhawan S; Diamond MS; Chen CC; Wechsler-Reya RJ; Gage FH; Hu H; Siqueira-Neto JL; Muotri AR; Cheresh DA; Rich JN
    Cell Stem Cell; 2020 Feb; 26(2):187-204.e10. PubMed ID: 31956038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity.
    Zou J; Xie X; Luo H; Shan C; Muruato AE; Weaver SC; Wang T; Shi PY
    EBioMedicine; 2018 Oct; 36():92-102. PubMed ID: 30201444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity.
    Qi Z; Zhao J; Li Y; Zhang B; Hu S; Chen Y; Ma J; Shu Y; Wang Y; Cheng P
    Front Immunol; 2023; 14():982180. PubMed ID: 37114043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic Effect of Zika Virus in Neuroendocrine Pancreatic Tumors: New Perspectives for Therapeutic Approaches.
    Cocco MM; Carcione C; Miceli V; Tinnirello R; Chinnici CM; Carbone C; Zito G; Conaldi PG; Iannolo G
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors.
    Wang G; Cao J; Gui M; Huang P; Zhang L; Qi R; Chen R; Lin L; Han Q; Lin Y; Chen T; He P; Ma J; Fu R; Hong J; Wu Q; Yu H; Chen J; Huang C; Zhang T; Yuan Q; Zhang J; Chen Y; Xia N
    J Exp Clin Cancer Res; 2023 Oct; 42(1):284. PubMed ID: 37891570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AXL receptor is required for Zika virus strain MR-766 infection in human glioblastoma cell lines.
    Zwernik SD; Adams BH; Raymond DA; Warner CM; Kassam AB; Rovin RA; Akhtar P
    Mol Ther Oncolytics; 2021 Dec; 23():447-457. PubMed ID: 34901388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zika Virus Selectively Kills Aggressive Human Embryonal CNS Tumor Cells
    Kaid C; Goulart E; Caires-Júnior LC; Araujo BHS; Soares-Schanoski A; Bueno HMS; Telles-Silva KA; Astray RM; Assoni AF; Júnior AFR; Ventini DC; Puglia ALP; Gomes RP; Zatz M; Okamoto OK
    Cancer Res; 2018 Jun; 78(12):3363-3374. PubMed ID: 29700002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment.
    Francipane MG; Douradinha B; Chinnici CM; Russelli G; Conaldi PG; Iannolo G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDK4/6 Inhibition Enhances Oncolytic Virus Efficacy by Potentiating Tumor-Selective Cell Killing and T-cell Activation in Refractory Glioblastoma.
    Xiao J; Liang J; Fan J; Hou P; Li X; Zhang H; Li K; Bu L; Li P; He M; Zhong Y; Guo L; Jia P; Xiao Q; Wu J; Peng H; Li C; Xing F; Guo D
    Cancer Res; 2022 Sep; 82(18):3359-3374. PubMed ID: 35792620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zika virus has oncolytic activity against glioblastoma stem cells.
    Zhu Z; Gorman MJ; McKenzie LD; Chai JN; Hubert CG; Prager BC; Fernandez E; Richner JM; Zhang R; Shan C; Tycksen E; Wang X; Shi PY; Diamond MS; Rich JN; Chheda MG
    J Exp Med; 2017 Oct; 214(10):2843-2857. PubMed ID: 28874392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors.
    Novaes GM; Lima C; Longo C; Machado PH; Silva TP; Olberg GGO; Módolo DG; Pereira MCL; Santos TG; Zatz M; Lagares D; de Franco M; Ho PL; Bulstrode H; Okamoto OK; Kaid C
    Mol Ther; 2024 Feb; 32(2):440-456. PubMed ID: 38213031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic stability of live-attenuated Zika vaccine candidates.
    Muruato AE; Shan C; Fontes-Garfias CR; Liu Y; Cao Z; Gao Q; Weaver SC; Shi PY
    Antiviral Res; 2019 Nov; 171():104596. PubMed ID: 31493417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
    Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural progenitor cells.
    Bulstrode H; Girdler GC; Gracia T; Aivazidis A; Moutsopoulos I; Young AMH; Hancock J; He X; Ridley K; Xu Z; Stockley JH; Finlay J; Hallou C; Fajardo T; Fountain DM; van Dongen S; Joannides A; Morris R; Mair R; Watts C; Santarius T; Price SJ; Hutchinson PJA; Hodson EJ; Pollard SM; Mohorianu I; Barker RA; Sweeney TR; Bayraktar O; Gergely F; Rowitch DH
    Neuron; 2022 Dec; 110(23):3936-3951.e10. PubMed ID: 36174572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.